Skip to content

UroGen Pharma Ltd

US · URGN #2773 by market cap Listed 2017
27.65 -4.08 -12.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 62.20 +125.0%
Price target rangecurrent 27.65
Low56.00
Avg62.20
High75.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-05 Piper Sandler -- Buy 58.00
2026-11-05 Ladenburg Thalmann -- Buy 62.00
2026-11-05 H.C. Wainwright -- Buy 75.00
2026-11-05 Oppenheimer -- Buy 60.00
2026-11-04 Guggenheim -- Buy 56.00
2026-11-03 H.C. Wainwright -- Buy 75.00
2026-10-28 Oppenheimer -- Buy 60.00
2026-10-19 Guggenheim -- Buy 58.00
2026-10-19 H.C. Wainwright -- Buy 75.00
2026-08-21 H.C. Wainwright -- Buy 75.00
2026-08-20 H.C. Wainwright -- Buy 75.00
2026-08-11 H.C. Wainwright -- Buy 75.00
2026-08-06 H.C. Wainwright -- Buy 75.00
2026-08-06 Oppenheimer -- Buy 60.00
2026-08-05 TD Cowen -- Buy 60.00
2026-08-05 Goldman Sachs -- Hold 48.00
2026-08-05 Guggenheim -- Buy 58.00
2026-07-21 Guggenheim -- Buy 42.00
2026-07-20 TD Cowen -- Buy 50.00
2026-07-16 H.C. Wainwright -- Buy 45.00
2026-07-16 Oppenheimer -- Buy 50.00
2026-07-15 Goldman Sachs -- Hold 44.00
2026-07-09 H.C. Wainwright -- Buy 45.00
2026-06-16 TD Cowen -- Buy 35.00
2026-06-03 H.C. Wainwright -- Buy 45.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 -- ±15.78% -16.45% (beat)
2026/Q2 2026-08-05 -- ±16.78% +16.31% (in line)
2026/Q1 2026-05-06 -- ±16.51% +10.16% (in line)
2025/Q4 2026-03-02 -- ±19.22% -12.35% (in line)
2025/Q3 2025-11-06 -- ±29.01% +21.91% (in line)
2025/Q2 2025-08-07 -- ±13.32% -7.10% (in line)
2025/Q1 2025-05-12 -- ±25.06% +7.32% (in line)
2024/Q4 2025-03-10 -- ±18.71% +1.02% (in line)
2024/Q3 2024-11-06 -- ±14.91% +0.25% (in line)
2024/Q2 2024-08-13 -- ±19.85% +3.10% (in line)
2024/Q1 2024-05-13 -- ±17.20% +2.59% (in line)
2023/Q4 2024-03-14 -- ±12.82% -17.97% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

UroGen Pharma Ltd discussion 0 comments

Add a comment